Physician profile
Jane S Smith
NPI 1568710994
$682.97
in general payments reported to CMS, 2019-2025
11 companies · $266 in 2025
The $266 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $72.90 · 2022: $93.59 · 2023: $230 · 2024: $20.39 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $136.91 | 2025 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $109.22 | 2023 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $83.19 | 2023 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $77.83 | 2021-2023 | Lifevest |
| Boston Scientific Corporation | $68.57 | 2021-2025 | Avvigo Guidance System |
| Novartis Pharmaceuticals Corporation | $49.84 | 2021-2025 | |
| Baxter Healthcare | $42.84 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $40.01 | 2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $34.34 | 2021 | |
| Irhythm Technologies, INC. | $20.39 | 2024 | Zio Monitor, Zio Xt Patch |
| W. L. Gore & Associates, INC. | $19.83 | 2025 | Gore Viabahn Vbx Balloon Expandable Endo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.